Codexis, Inc.

CDXS Healthcare Biotechnology

Codexis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.4 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 2.69%, EPS grew 18.8%, free cash flow grew 48.6% and total debt fell 14.1%, each against the same quarter a year earlier.

1.25 0.11 −8.09%
Market cap
$148.9M
P/E
0.0×
Fwd P/E
−6.6×
Dividend yield
—
F-score
4/9
Altman Z
−4.75
Beneish M
−3.57
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
4.16 2.02 1.89 2.65
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(28.59) 7.07 (11.25) (21.34)
P/B ratio
5.71 2.81 3.42 6.24
Price to Tangible BV
6.10 2.96 3.63 6.75
EV/Sales
3.79 1.47 1.57 2.37
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(3.59) (5.34) (6.56) (17.71)
EV/FCF
(3.26) (4.34) (5.56) (15.15)
Quick Ratio
3.62 3.51 4.93 2.66
Current Ratio
4.12 3.82 5.36 3.06
Net Debt/EBITDA
1.13 (3.09) 4.14 2.31
Debt/Assets
32.05% 27.14% 31.29% 28.17%
Debt/Equity
1.03 0.79 0.94 1.03
Asset Turnover
0.39 0.47 0.60 0.60
Operating CF/Net income
0.39 2.09 1.51 0.80
Capex/Depreciation
(0.10) (0.27) (0.09) (0.46)
Interest Coverage
(14.67) 6.62 (6.23) (8.63)
Research and Development Expense of Revenue
161.24% 30.12% 75.08% 78.48%
Selling, General and Administrative Expense of Revenue
130.42% 28.74% 64.13% 73.26%
Intangible Assets out of Total Assets
0.02 0.02 0.02 0.02
Share Based Compensation of Revenue
29.22% 5.65% 9.37% 10.61%
Graham Net Nets
(0.04) 0.00 (0.04) (0.07)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(31.15%) (31.90%) (22.70%) (15.04%)
Free Cash Flow Yield
(28.00%) (16.79%) (14.95%) (5.91%)
Revenue per Share
0.10 0.45 0.17 0.16
Operating CF per Share
(0.09) 0.23 (0.14) (0.11)
Capex per Share
0.00 (0.01) 0.00 (0.01)
Free Cash Flow per Share
(0.09) 0.22 (0.15) (0.12)
Cash per Share
0.66 0.90 0.72 0.61
Shareholders Equity per Share
0.43 0.58 0.48 0.36
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.43 0.58 0.48 0.36
Free Cash Flow
(7.88) 19.57 (13.33) (10.53)
Working Capital
57.72 71.50 64.80 48.41
Capital Expenditures
(0.18) (0.52) (0.18) (0.88)
Net Current Asset Value
(9.22) (0.45) (6.49) (15.18)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.02 0.01 0.01 0.06
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
10.36 12.35 8.69 11.26
Average Payables
3.32 2.20 4.09 2.04
Average Inventory
2.02 1.81 1.89 1.77
Average Assets
136.07 148.40 129.13 129.15
Average Common Equity
55.97 58.73 46.43 44.29

Fold the line items

Columns are period end dates